Sadat-Ali Mir, Al Elq Abdulmohsen H, Al-Turki Haifa A, Al-Mulhim Fathma A, Al-Ali Amein K
Department of Orthopaedic Surgery, College of Medicine, King Faisal University, Dammam, and King Fahd University Hospital, Al Khobar, Saudi Arabia.
Ann Saudi Med. 2011 Nov-Dec;31(6):602-8. doi: 10.4103/0256-4947.87097.
The effects of vitamin D on bone mass remain to be understood. This study was conducted with the objective of evaluating the influence of 25-hydroxyvitamin D (25OHD) levels on bone mineral density (BMD) among Saudi nationals.
Cross-sectional study carried out at university hospital from 1 February 2008 to 31 May 2008.
Healthy Saudi men and women in the peak bone mass (PBM) age group and those aged ≥ 50 years were recruited from the outpatient department of King Fahd University Hospital, Al Khobar, Saudi Arabia, between February 1, 2008, and May 31, 2008. Patient age and sex were documented, and body mass index was calculated. Hematological, biochemical, and serum 25OHD tests were performed. BMD was determined by dual-energy x-ray absorptiometry of the upper femur and lumbar spine. Patients were divided into three groups, based on their 25OHD level.
Data from 400 patients were analyzed. Among individuals with a normal 25OHD level, 50% of women and 7% of men in the PBM age group and 26.4% of women and 49.2% of men aged ≥ 50 years had low bone mass. In patients with 25OHD insufficiency, 84.2% of women and 88.9% of men in the PBM age group and 83.3% of women and 80% of men aged ≥ 50 years had low bone mass. Results for patients with 25OHD deficiency revealed that none of the men and women in the PBM age group or ≥ 50 years old had normal BMD. Significant positive correlations between 25OHD level and BMD and significant negative correlations with parathyroid hormone were shown in most of the groups.
This study showed that the vitamin D level significantly influences BMD reading among Saudi individuals. Evaluation and treatment of hypovitaminosis D should be considered during management of low bone mass.
维生素D对骨量的影响尚待明确。本研究旨在评估沙特国民中25-羟维生素D(25OHD)水平对骨密度(BMD)的影响。
于2008年2月1日至2008年5月31日在大学医院开展的横断面研究。
2008年2月1日至2008年5月31日期间,从沙特阿拉伯胡拜尔法赫德国王大学医院门诊部招募处于骨量峰值(PBM)年龄组的健康沙特男性和女性以及年龄≥50岁的人群。记录患者的年龄和性别,并计算体重指数。进行血液学、生化和血清25OHD检测。通过双能X线吸收法测定股骨上段和腰椎的骨密度。根据患者的25OHD水平将其分为三组。
分析了400例患者的数据。在25OHD水平正常的个体中,PBM年龄组中50%的女性和7%的男性以及年龄≥50岁的人群中26.4%的女性和49.2%的男性骨量较低。在25OHD不足的患者中,PBM年龄组中84.2%的女性和88.9%的男性以及年龄≥50岁的人群中83.3%的女性和80%的男性骨量较低。25OHD缺乏患者的结果显示,PBM年龄组或年龄≥50岁的男性和女性均无正常骨密度。大多数组中25OHD水平与骨密度呈显著正相关,与甲状旁腺激素呈显著负相关。
本研究表明,维生素D水平对沙特个体的骨密度读数有显著影响。在低骨量管理过程中应考虑对维生素D缺乏症进行评估和治疗。